GU Cancers Symposium 2014 - Heterogeneity of intermediate prognosis patients with metastatic renal cell cancer treated with sunitinib - Poster

SAN FRANCISCO, CA USA ( - Presented by Avishay Sella, M. Dror Michaelson, Ewa M. Matczak, Ronit Simantov, Mariajose Lechuga, Xun Lin, and Robert A. Figlin at the 2014 Genitourinary Cancers Symposium - January 30 - February 1, 2014 - San Francisco Marriott Marquis - San Francisco, California USA

gucancer 2014 Sella IntermediateRisk Poster thumb

Assaf Harofeh Medical Center, Zerifin, Israel; Massachusetts General Hospital, Boston, MA; Pfizer Oncology, New York, NY; Pfizer Oncology, Pfizer Italia Srl, Milan, Italy; Pfizer Oncology, San Diego, CA; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA